BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,233,796 | +64.2% | 602,027 | +106.6% | 0.35% | +62.4% |
| Q2 2023 | $18,414,078 | +288.4% | 291,362 | +176.5% | 0.22% | +240.6% |
| Q1 2023 | $4,740,911 | -55.0% | 105,377 | -56.2% | 0.06% | -54.6% |
| Q4 2022 | $10,544,804 | +71.4% | 240,694 | +157.7% | 0.14% | +64.0% |
| Q3 2022 | $6,153,000 | +4.9% | 93,387 | -19.6% | 0.09% | -4.4% |
| Q2 2022 | $5,864,000 | +269.0% | 116,087 | +366.7% | 0.09% | +246.2% |
| Q1 2022 | $1,589,000 | -76.1% | 24,873 | -59.9% | 0.03% | -72.6% |
| Q4 2021 | $6,647,000 | -62.4% | 62,055 | -63.9% | 0.10% | -67.1% |
| Q3 2021 | $17,687,000 | +252.4% | 172,035 | +201.5% | 0.29% | +207.4% |
| Q2 2021 | $5,019,000 | -41.9% | 57,056 | -35.8% | 0.09% | -51.0% |
| Q1 2021 | $8,644,000 | – | 88,906 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |